XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
SVS Shares (as converted)
Share Capital
Accumulated Other Comprehensive Income
Accumulated Earnings (Deficit)
Non-Controlling Interest
Limited Liability Company (LLC) Members' Equity [Abstract]            
LLC Membership Units, outstanding (in shares) 279,900,000          
Issuance of Pubco shares in redemption of membership units (in shares) (279,900,000)          
Beginning balance at Dec. 31, 2020 $ 153,398   $ 137,914   $ 9,247 $ 6,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   932,525        
Share-based compensation 34,923   34,923      
Issuance of shares in conjunction with acquisitions (in shares)   20,653,051        
Issuance of shares in conjunction with acquisitions 381,302   381,302      
RTO-related issuances, net 652,217   652,217      
Issuance of Pubco shares in redemption of membership units (in shares)   279,900,000        
Reverse takeover ("RTO Financing"), net (in shares)   10,100,000        
Reverse takeover (“RTO Financing”), net 95,420   95,420      
Purchase of Non-controlling interest (12,265)   505   (6,975) (5,795)
Distributions to minority holders (1,475)         (1,475)
Warrants issued and exercised (in shares)   3,510,000        
Warrants issued and exercised 75,100   75,100      
Contingent consideration & other adjustments to purchase accounting (in shares)   103,775        
Contingent consideration & other adjustments to purchase accounting 2,085   2,085      
Net income (loss) (48,172)       (50,087) 1,915
Ending balance (in shares) at Sep. 30, 2021   315,199,351        
Ending balance at Sep. 30, 2021 1,332,533   1,379,466   (47,815) 882
Beginning balance (in shares) at Jun. 30, 2021   307,223,181        
Beginning balance at Jun. 30, 2021 1,233,041   1,253,867   (28,327) 7,501
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   932,525        
Share-based compensation 13,826   13,826      
Issuance of shares in conjunction with acquisitions (in shares)   7,043,645        
Issuance of shares in conjunction with acquisitions 111,268   111,268      
Purchase of Non-controlling interest (12,265)   505   (6,975) (5,795)
Distributions to minority holders (1,375)         (1,375)
Net income (loss) (11,962)       (12,513) 551
Ending balance (in shares) at Sep. 30, 2021   315,199,351        
Ending balance at Sep. 30, 2021 1,332,533   1,379,466   (47,815) 882
Beginning balance (in shares) at Dec. 31, 2021   324,312,662        
Beginning balance at Dec. 31, 2021 1,481,806   1,535,765   (55,235) 1,276
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   2,613,337        
Share-based compensation 36,664   36,664      
Issuance of shares in conjunction with acquisitions (in shares)   3,925,683        
Issuance of shares in conjunction with acquisitions 31,116   31,116      
Non-controlling interest adjustment for change in ownership (1,567)         (1,567)
Foreign Currency Translation Adjustment 103     $ 103    
Contingent consideration & other adjustments to purchase accounting (in shares)   5,310,540        
Contingent consideration & other adjustments to purchase accounting 44,935   44,935      
Net income (loss) (52,763)       (53,054) 291
Ending balance (in shares) at Sep. 30, 2022   336,162,222        
Ending balance at Sep. 30, 2022 1,540,294   1,648,480 103 (108,289) 0
Beginning balance (in shares) at Jun. 30, 2022   330,818,664        
Beginning balance at Jun. 30, 2022 1,548,725   1,614,021   (65,296) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   1,815,430        
Share-based compensation 12,399   12,399      
Issuance of shares in conjunction with acquisitions (in shares)   1,714,358        
Issuance of shares in conjunction with acquisitions 12,356   12,356      
Foreign Currency Translation Adjustment 103     103    
Contingent consideration & other adjustments to purchase accounting (in shares)   1,813,770        
Contingent consideration & other adjustments to purchase accounting 9,704   9,704      
Net income (loss) (42,993)       (42,993)  
Ending balance (in shares) at Sep. 30, 2022   336,162,222        
Ending balance at Sep. 30, 2022 $ 1,540,294   $ 1,648,480 $ 103 $ (108,289) $ 0